The FDA Has Cleared Centessa Pharmaceuticals' Investigational New Drug Application To Initiate A Phase 1 First-in-human, Clinical Trial Of ORX750 For Narcolepsy
The FDA Has Cleared Centessa Pharmaceuticals' Investigational New Drug Application To Initiate A Phase 1 First-in-human, Clinical Trial Of ORX750 For Narcolepsy
美国食品药品管理局已批准 Centessa Pharmaceuticals 的研究性新药申请，以启动 ORX750 治疗发作性睡病的 1 期首次人体临床试验
The FDA Has Cleared Centessa Pharmaceuticals' Investigational New Drug Application To Initiate A Phase 1 First-in-human, Clinical Trial Of ORX750 For Narcolepsy
美国食品药品管理局已批准 Centessa Pharmaceuticals 的研究性新药申请，以启动 ORX750 治疗发作性睡病的 1 期首次人体临床试验
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。